Semret Makeda, Schiller Ian, Jardin Barbara Ann, Frenette Charles, Loo Vivian G, Papenburg Jesse, McNeil Shelly A, Dendukuri Nandini
Division of Infectious diseases and Medical Microbiology, Department of Medicine and Laboratories.
Research Institute.
J Infect Dis. 2017 Nov 15;216(8):936-944. doi: 10.1093/infdis/jix288.
Respiratory tract infections are frequent causes of hospitalization and initiation of empirical antimicrobial therapy. Testing for a broad panel of respiratory viruses has been advocated as a useful tool for antibiotic stewardship. We conducted a prospective observational study to assess the impact of rapid viral test results on antimicrobial prescriptions and clinical outcomes among hospitalized adults.
Eight hundred patients admitted with respiratory symptoms were tested by a 12-virus respiratory panel (RVP) during 3 consecutive winters in Montreal, Canada. The primary outcome measure was change in antimicrobial prescriptions (ie, de-escalation of empirical antimicrobial therapy or commencement of new antimicrobial therapy) after RVP results were available. Clinical outcomes were also assessed.
Influenza virus was identified in 53% of individuals in the study population, and other viruses were identified in 10%. Influenza virus positivity was associated with shorter duration of hospitalization and appropriate antiviral management. Antibiotic management was most significantly correlated with radiographic suspicion of pneumonia and less so with results of the RVP. Positivity for viruses other than influenza virus was not correlated with significantly different outcomes.
Physicians respond to results of testing for influenza virus when managing hospitalized adult patients but respond less to test results for other viruses. These data can inform the design of stewardship interventions and the selection of viral testing panels for hospitalized patients.
呼吸道感染是住院治疗和启动经验性抗菌治疗的常见原因。对多种呼吸道病毒进行检测已被倡导作为抗生素管理的一项有用工具。我们开展了一项前瞻性观察性研究,以评估快速病毒检测结果对住院成人抗菌药物处方及临床结局的影响。
在加拿大蒙特利尔连续三个冬季,对800例有呼吸道症状的住院患者采用12种病毒的呼吸道病毒检测组合(RVP)进行检测。主要结局指标是RVP结果出来后抗菌药物处方的变化(即经验性抗菌治疗的降级或新抗菌治疗的开始)。同时也评估临床结局。
研究人群中53%的个体检测出流感病毒,10%检测出其他病毒。流感病毒阳性与住院时间缩短及适当的抗病毒治疗管理相关。抗生素管理与肺炎的影像学疑似情况相关性最强,与RVP结果的相关性较弱。除流感病毒外的其他病毒阳性与显著不同的结局无相关性。
在管理住院成年患者时,医生会对流感病毒检测结果做出反应,但对其他病毒的检测结果反应较少。这些数据可为管理干预措施的设计及住院患者病毒检测组合的选择提供参考。